title: SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
abstract: K63- and Met1-linked ubiquitylation are crucial posttranslational modifications for TNF receptor signaling. These non-degradative ubiquitylations are counteracted by deubiquitinases (DUBs), such as the enzyme CYLD, resulting in an appropriate signal strength, but the regulation of this process remains incompletely understood. Here, we describe an interaction partner of CYLD, SPATA2, which we identified by a mass spectrometry screen. We find that SPATA2 interacts via its PUB domain with CYLD, while a PUB interaction motif (PIM) of SPATA2 interacts with the PUB domain of the LUBAC component HOIP SPATA2 is required for the recruitment of CYLD to the TNF receptor signaling complex upon TNFR stimulation. Moreover, SPATA2 acts as an allosteric activator for the K63- and M1-deubiquitinase activity of CYLD In consequence, SPATA2 substantially attenuates TNF-induced NF-κB and MAPK signaling. Conversely, SPATA2 is required for TNF-induced complex II formation, caspase activation, and apoptosis. Thus, this study identifies SPATA2 as an important factor in the TNF signaling pathway with a substantial role for the effects mediated by the cytokine.
authors.affiliation: Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany BIOSS, Centre for Biological Signaling Studies, Freiburg, Germany.
authors.forename: Lisa
authors.initials: L
authors.lastname: Schlicher
authors.affiliation: Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
authors.forename: Manuela
authors.initials: M
authors.lastname: Wissler
authors.affiliation: Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany.
authors.forename: Florian
authors.initials: F
authors.lastname: Preiss
authors.affiliation: Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany.
authors.forename: Prisca
authors.initials: P
authors.lastname: Brauns-Schubert
authors.affiliation: Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
authors.forename: Celia
authors.initials: C
authors.lastname: Jakob
authors.affiliation: Core Facility Proteomics, Center for Biological Systems Analysis, Freiburg, Germany.
authors.forename: Veronica
authors.initials: V
authors.lastname: Dumit
authors.affiliation: Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany BIOSS, Centre for Biological Signaling Studies, Freiburg, Germany.
authors.forename: Christoph
authors.initials: C
authors.lastname: Borner
authors.affiliation: BIOSS, Centre for Biological Signaling Studies, Freiburg, Germany Core Facility Proteomics, Center for Biological Systems Analysis, Freiburg, Germany.
authors.forename: Joern
authors.initials: J
authors.lastname: Dengjel
authors.affiliation: Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany BIOSS, Centre for Biological Signaling Studies, Freiburg, Germany ulrich.maurer@mol-med.uni-freiburg.de.
authors.forename: Ulrich
authors.identifier: 0000-0002-2504-1517
authors.initials: U
authors.lastname: Maurer
mesh_terms: D000818:Animals; D064113:CRISPR-Cas Systems; D016923:Cell Death / Q000187:drug effects / Q000235:genetics; D002460:Cell Line; D000074749:Deubiquitinating Enzyme CYLD; D055786:Gene Knockout Techniques; D018390:Gene Targeting; D006801:Humans; D020935:MAP Kinase Signaling System / Q000187:drug effects; D051379:Mice; D008954:Models, Biological; D046912:Multiprotein Complexes / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D011485:Protein Binding; D011506:Proteins / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D025521:Tumor Suppressor Proteins / Q000172:deficiency / Q000378:metabolism*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism
chemical_list: D046912:Multiprotein Complexes; D016328:NF-kappa B; D011506:Proteins; C425523:SPATA2 protein, human; D014409:Tumor Necrosis Factor-alpha; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; C409984:CYLD protein, human; D000074749:Deubiquitinating Enzyme CYLD
keywords: CYLD; HOIP; SPATA2; TNF; apoptosis